Form 8-K - Current report:
SEC Accession No. 0000950170-25-055883
Filing Date
2025-04-18
Accepted
2025-04-18 16:30:20
Documents
11
Period of Report
2025-04-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K pstv-20250417.htm   iXBRL 8-K 45286
  Complete submission text file 0000950170-25-055883.txt   167895

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pstv-20250417.xsd EX-101.SCH 30909
14 EXTRACTED XBRL INSTANCE DOCUMENT pstv-20250417_htm.xml XML 4694
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 25850663
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)